28 / 84
268
Ces Urol 2015; 19(4): 256–269
PŘEHLEDOVÝ ČLÁNEK
24. Barry MJ, Gallagher PM, Skinner JS, et al.
Adverse effects of robotic-assisted laparoscopic versus open
retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol
2012; 30(5): 513–518.
25. Hu JC, Gu X, Lipsitz SR, et al.
Comparative effectiveness of minimally invasive vs open radical prosta‑
tectomy. Jama 2009; 302(14): 1557–1564.
26. Nguyen PL, Gu X, Lipsitz SR, et al.
Cost implications of the rapid adoption of newer technologies for
treating prostate cancer. J Clin Oncol 2011; 29(12): 1517–1524.
27. Schroeck FR, Krupski TL, Sun L, et al.
Satisfaction and regret after open retropubic or robot-assisted
laparoscopic radical prostatectomy. Eur Urol 2008; 54(4): 785–793.
28. Ramsay C, Pickard R, Robertson C, et al.
Systematic review and economic modelling of the relative
clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the
prostate in men with localised prostate cancer. Health Technol Assess. 2012; 16(41): 1–313.
29. Djavan B, Eckersberger E, Finkelstein J, et al.
Oncologic, functional, and cost analysis of open, lapa‑
roscopic, and robotic radical prostatectomy. Eur Urol Suppl 2010; 9(3): 371–378.
30. Hara I, Kawabata G, Miyake H, et al.
Comparison of quality of life following laparoscopic and open
prostatectomy for prostate cancer. J Urol 2003; 169(6): 2045–2048.
31. Sammon JD, Karakiewicz PI, Sun M, et al.
Robot-assisted versus open radical prostatectomy: the diffe‑
rential effect of regionalization, procedure volume and operative approach. J Urol 2013; 189(4): 1289–1294.
32. Bivalacqua TJ, Pierorazio PM, Su LM.
Open, laparoscopic and robotic radical prostatectomy: optimizing
the surgical approach. Surg Oncol 2009; 18(3): 233–241.
33. Rosoff JS, Savage SJ, Prasad SM.
Salvage radical prostatectomy as management of locally recurrent
prostate cancer: outcomes and complications. W J Urol 2013; 31(6): 1347–1352.
34. Kimura M, Mouraviev V, Tsivian M, et al.
Current salvage methods for recurrent prostate cancer after
failure of primary radiotherapy. BJU Int 2010; 105(2): 191–201.
35. Chade DC, Eastham J, Graefen M, et al.
Cancer control and functional outcomes of salvage radical
prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 2012;
61(5): 961–71.
36. Ismail M, Ahmed S, Kastner C, Davies J.
Salvage cryotherapy for recurrent prostate cancer after radia‑
tion failure: a prospective case series of the first 100 patients. BJU Int 2007; 100(4): 760–764.
37. Dearnaley D, Syndikus I, Sumo G, et al.
Conventional versus hypofractionated highdose intensity-mo‑
dulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled
trial. Lancet Oncol 2012; 13(1): 43–54.
38. Peeters ST, Heemsbergen WD, Koper PC, et al.
Dose-response in radiotherapy for localized prostate
cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with
78 Gy. J Clin Oncol 2006; 24(13): 1990–1996.
39. Pollack A, Zagars GK, Smith LG, et al.
Preliminary results of a randomized radiotherapy dose-escalation
study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 2000; 18(23): 3904–3911.
40. Zelefsky MJ, Leibel SA, Gaudin PB, et al.
Dose escalation with three-dimensional conformal radiation
therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41(3): 491–500.
41. Zietman AL, DeSilvio ML, Slater JD, et al.
Comparison of conventional-dose vs highdose conformal
radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. J Am
Med Assoc 2005; 294(10): 1233–1239.
42. Boehmer D, Maingon P, Poortmans P, et al.
Guidelines for primary radiotherapy of patients with
prostate cancer. Radiother Oncol 2006; 79(3): 259–69.
43. Poortmans P, et al.
Guidelines for target volume definition in post-operative radiotherapy for prostate
cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 2007; 84(2): 121–127.